Performance by category
Death-per-report rate within each category, compared to the corpus-wide average for that same category. Ratio > 1 means this manufacturer's mortality is higher than the field for that category; ratio < 1 means lower.
| Category | Devices | Reports | Deaths | Death rate | Corpus avg | vs corpus |
|---|---|---|---|---|---|---|
| DBS / neuromodulation | 48 | 108,729 | 341 | 0.31% | 1.53% | 0.21× |
| Cranial surgery | 12 | 57,421 | 235 | 0.41% | 0.38% | 1.09× |
| Neurovascular | 8 | 3,464 | 206 | 5.95% | 2.52% | 2.36× |
Temporal trajectory
Annual reports for this manufacturer's neurosurgical devices, split by FDA event type. Use it to spot inflection points (recall responses, product launches, reporting-pattern shifts).
Failure-mode signature
Per category, this manufacturer's failure-mode mix vs other manufacturers in the SAME category — an apples-to-apples comparison that strips out the confound of "which categories they happen to operate in." Click a category tab to drill in.
Highest-mortality devices
Top 10 of this manufacturer's devices ranked by death-per-report rate (minimum 100 reports to avoid small-sample noise). Click any device for its full profile.
| Device | Category | Reports | Deaths | Death rate |
|---|---|---|---|---|
| Abbott RX Acculink Carotid Stent | Neurovascular | 1,985 | 188 | 9.47% |
| Abbott Axium | DBS / neuromodulation | 402 | 35 | 8.71% |
| Abbott Perclose | Cranial surgery | 310 | 10 | 3.23% |
| Abbott Prostar XL | Cranial surgery | 1,389 | 44 | 3.17% |
| Abbott Hi-Torque Whisper MS | Neurovascular | 408 | 9 | 2.21% |
| Abbott Trial Slim Tip Lead | DBS / neuromodulation | 246 | 5 | 2.03% |
| Abbott Brio | DBS / neuromodulation | 178 | 3 | 1.69% |
| Abbott Infinity DBS Lead Kit | DBS / neuromodulation | 1,088 | 15 | 1.38% |
| Abbott Proclaim | DBS / neuromodulation | 149 | 2 | 1.34% |
| Abbott Infinity DBS Lead | DBS / neuromodulation | 549 | 6 | 1.09% |